FDA-approved
Articles tagged FDA-approved from Bright Horizons Psychiatry.
-
Spravato REMS Program Explained for Maryland Patients
The Spravato REMS program is why the two hour monitoring rule exists. Here is how enrollment works and what Maryland patients should expect.
Read more
-
Spravato vs IV Ketamine vs IM Ketamine Compared
Spravato, IV ketamine, and IM ketamine are related but not interchangeable. Here is how they compare on evidence, cost, insurance, and monitoring.
Read more
-
Common Questions About Esketamine Nasal Spray
Esketamine nasal spray offers rapid relief for treatment-resistant depression, requiring close supervision and specific eligibility criteria.
Read more
-
Spravato vs Traditional Antidepressants: Key Differences
Explore the differences between Spravato and traditional antidepressants in terms of effectiveness, administration, and side effects for treating depression.
Read more
-
Spravato (Esketamine) for Treatment-Resistant Depression
Spravato is an FDA-approved esketamine nasal spray for treatment-resistant depression. Here is how it works, who qualifies, and what treatment involves.
Read more
-
Esketamine Treatment in Maryland: What to Expect at Bright Horizons Psychiatry
Esketamine treatment in Maryland follows a set protocol with in-clinic dosing and monitoring. Here is what to expect from your first session onward.
Read more
-
Challenging the Norm: Esketamine Treatment in Medication Management
Esketamine changed what medication management can offer adults with treatment-resistant depression. Here is how it works and who it suits.
Read more